Independent regulation of the cycle and acceleration in Parkinsonian gait analyzed by a long-term daily monitoring system

European Neurology

Volumn 69, Issue 3, 2013, Pages 134-141

  Terashi, Hiroo ^a   Utsumi, Hiroya ^a   Ishimura, Yohei ^a   Mitoma, Hiroshi ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Gait acceleration; Gait cycle; Parkinson's disease; Portable gait rhythmogram

Indexed keywords

AGED; ARTICLE; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DISEASE CLASSIFICATION; FEMALE; GAIT; GAIT DISORDER; HOEHN AND YAHR SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROLOGICAL EQUIPMENT; PARKINSON DISEASE; PORTABLE GAIT RHYTHMOGRAM; PRIORITY JOURNAL; UNIFIED PARKINSON DISEASE RATING SCALE; WALKING SPEED;

EID: 84870764539     PISSN: 00143022     EISSN: 14219913     Source Type: Journal    
DOI: 10.1159/000345266     Document Type: Article

References (17)

1. Giladi N: Gait disturbances in advanced stages of Parkinson's disease. Adv Neurol 2001; 86: 273-278
2. Tan D, Danoudis M, McGinley J, Morris ME: Relationships between motor aspects of gait impairments and activity limitations in people with Parkinson's disease: A systematic review. Parkinsonism Relat Disord 2012; 18: 117-124
3. Sudarsky L: Gait disorders: Prevalence, morbidity, and etiology. Adv Neurol 2001; 87: 111-117
4. Morris M, Iansek R, McGinley J, Matyas T, Huxham F: Three-dimensional gait biomechanics in Parkinson's disease: evidence for a centrally mediated amplitude regulation disorder. Mov Disord 2005; 20: 40-50
5. Sofuwa O, Nieuwboer A, Desloovere K, Willems AM, Chavret F, Jonkers I: Quantitative gait analysis in Parkinson's disease: comparison with a healthy control group. Arch Phys Med Rehabil 2005; 86: 1007-1013
6. Weiss A, Sharifi S, Plotnik M, van Vugt JP, Giladi N, Hausdorff JM: Toward automated, at-home assessment of mobility among patients with Parkinson disease, using a bodyworn accelerometer. Neurorehabil Neural Repair 2011; 25: 810-818
7. Mitoma H, Yoneyama M, Orimo S: 24-hour recording of parkinsonian gait using a portable gait rhythmogram. Intern Med 2010; 49: 2401-2408
8. Utsumi H, Terashi H, Ishimura Y, Takazawa T, Hayashi A, Mochizuki H, Okuma Y, Orimo S, Takahashi K, Yoneyama M, Mitoma H: Quantitative assessment of gait bradykinesia in Parkinson's disease using a portable gait rhythmogram. Acta Med Okayama 2012; 66: 31-40
9. Gibb WR, Lees AJ: The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988; 51: 745-752
10. Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE: Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord 2010; 25: 2649-2653
11. O'Sullivan JD, Said CM, Dillon LC, Hoffman M, Hughes AJ: Gait analysis in patients with Parkinson's disease and motor fluctuations: influence of levodopa and comparison with other measures of motor function. Mov Disord 1998; 13: 900-906
12. Morris ME, Iansek R, Matyas TA, Summers JJ: Ability to modulate walking cadence remains intact in Parkinson's disease. J Neurol Neurosurg Psychiatry 1994; 57: 1532-1534
13. Mitoma H, Hayashi R, Yanagisawa N, Tsukagoshi H: Characteristics of parkinsonian and ataxic gaits: A study using surface electromyograms, angular displacements and floor reaction forces. J Neurol Sci 2000; 172: 22-39
14. Okuma Y, Yanagisawa N: The clinical spectrum of freezing of gait in Parkinson's disease. Mov Disord 2008; 23(suppl 2):426-430
15. Takakusaki K, Tomita N, Yano M: Substrates for normal gait and pathophysiology of gait disturbances with respect to the basal ganglia dysfunction. J Neurol 2008; 255(suppl 4):19-29
16. Knoll J: R-(-)-deprenyl (Selegiline, Movergan) facilitates the activity of the nigrostriatal dopaminergic neuron. J Neural Transm 1987; 25(suppl):45-66
17. Giladi N: Medical treatment of freezing of gait. Mov Disord 2008; 23(suppl 2):482-488.